Form 8-K · Current Report · Filed 2026-08-26
Agilent Reports Strong Q3 2026 Results and Raises FY26 Guidance
Agilent Technologies, Inc. reported third-quarter fiscal year 2026 revenue of $1.88 billion, representing growth of 8.1% reported and up 7.3% core compared with the third quarter of fiscal year 2025. The company reported GAAP net income of $362 million, or $1.28 per share, and non-GAAP net income of $459 million, or $1.62 per share. Agilent also raised its fiscal year 2026 revenue growth, margin expansion, and non-GAAP EPS guidance. The company now expects revenue in the range of $7.49 billion to $7.51 billion, non-GAAP operating margin expansion at the midpoint of core revenue growth guidance, and non-GAAP fiscal year 2026 EPS in the range of $6.18 to $6.21.
- Filer
- Agilent Technologies Inc. A · NYSE
- Filed
- Accession
- 0001090872-26-000062
- CIK
- 0001090872
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$154.78
Since filing
+0.0%
Latest close
$154.78
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from A reporting the same item, with the next session's move:
About Agilent Technologies Inc.
Agilent Technologies Inc. is a life sciences and analytical instruments company that provides application-focused solutions for laboratories and research environments. Agilent Technologies Inc. serves customers in life sciences, diagnostics, and applied chemical markets through a broad portfolio of instruments, software, consumables, and services. Its offerings support testing, measurement, and analysis across pharmaceutical, biotechnology, environmental, food safety, and industrial applications. The company also provides laboratory workflow support and service solutions through its Agilent CrossLab segment, helping organizations maintain and optimize scientific operations. Headquartered in Santa Clara, California, Agilent Technologies Inc. plays an important role in enabling precision research, quality control, and diagnostic testing across scientific and industrial markets.
Never miss another A filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.